August 19, 2024- Pelstar LLC, the manufacturer of Health o meter® Professional Scales, is proud to introduce the 565KL neonatal/pediatric scale specifically designed to meet the rigorous demands of healthcare professionals in critical environments such as NICUs, nurseries, delivery rooms and pediatric practices. This state-of-the-art scale ensures exceptional accuracy, … [Read more...]
HealthTrust Performance Group recognizes 2024 Member Award Recipients
August 16, 2024- HealthTrust Performance Group has recognized six member organizations for their commitment to excellence and demonstrated efforts in delivering exceptional performance. The recipients of the 2024 Member Recognition Awards were honored during the HealthTrust University Conference (HTU) in Orlando, Florida. The recipients of the HealthTrust 2024 Member … [Read more...]
Cleveland Clinic opens sleep disorders clinic at Lutheran Hospital
August 16, 2024- Cleveland Clinic Lutheran Hospital has added a sleep disorders clinic to the programs it offers to meet the unique needs of Hispanic patients in the community. The new clinic, which is being directed by Cinthya Pena Orbea, M.D., will be offered on Wednesdays initially, with more days added as needed to meet patient demand. More than half of Hispanic people … [Read more...]
Sg2’s new data solution unlocks market share insights for healthcare organizations
August 16, 2024- Sg2, a Vizient, Inc. company, announced the launch of Share of CARE™, its data solution providing visibility into clinical activity across all sites of care. These insights enable providers to optimize their care delivery models, improve patient access and experience and plan for enterprise growth in the communities they serve. The Share of … [Read more...]
Thermo Fisher Scientific Innovations achieve R&D 100 Awards
August 16, 2024- Thermo Fisher Scientific Inc. has received three R&D 100 Awards for innovations that aid researchers’ and scientists’ work in a variety of life science applications, including proteomics, bioproduction and small-molecule analysis. Notably, the Thermo Scientific™ Orbitrap™ Astral™ Mass Spectrometer (MS) won gold in the Market Disruptor special recognition … [Read more...]
Henry Schein to participate in upcoming investor conferences in September
August 16, 2024- Henry Schein, Inc. announced today that the Company will present at the following investor conferences in September: Morgan Stanley 22nd Annual Global Healthcare Conference in New York on September 5, 2024, at 11:30 a.m. Eastern time and the Baird 2024 Global Healthcare Conference in New York on September 10, 2024, … [Read more...]
Sebastian Junger to keynote Streamlining Healthcare Expo
August 15, 2024- Sebastian Junger, best-selling author of The Perfect Storm, War, and Tribe, will deliver the keynote remarks at HIDA’s Streamlining Healthcare Expo & Business Exchange, September 10-12, 2024 in Dallas. As an award-winning journalist, special correspondent at ABC News, and acclaimed filmmaker, Junger has documented the working lives of men and women in some … [Read more...]
AHA names new trustees to the board
August 13, 2024- The American Hospital Association (AHA) has elected eight members to its Board of Trustees for terms beginning Jan. 1, 2025. The Board of Trustees is the highest policymaking body of the AHA and has ultimate authority for the governance and management of its directions and finances. In addition, Michael Ugwueke, president and CEO of Methodist Le Bonheur … [Read more...]
Pfizer announces results of ABRYSVO® for RSV in immunocompromised adults
August 15, 2024- Pfizer Inc. announced positive top-line safety and immunogenicity results from substudy B of the ongoing pivotal Phase 3 clinical trial ( NCT05842967 ) MONeT (RSV I Mmunizati ONStudy for Adul Ts at Higher Risk of Severe Illness), evaluating two doses of ABRYSVO vaccine in immunocompromised adults aged 18 and older at risk of developing severe respiratory … [Read more...]
BD names Michael Feld as President of Life Sciences Segment
August 15, 2024- BD announced that Michael Feld has been named executive vice president and president of the Life Sciences segment for BD, effective Aug. 20, 2024, and will serve as a member of the Executive Leadership Team. He succeeds Dave Hickey, who retired from BD last month after 10 years with the company. Feld joins BD from Veralto, a spin-off of Danaher, where he was … [Read more...]